Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 166(9): 5374-80, 2001 May 01.
Article in English | MEDLINE | ID: mdl-11313373

ABSTRACT

Activation of murine macrophages (Mphi) requires the collaboration of signals derived from the immune system and the environment. In this study, we engineered a murine Mphi cell line to become activated in response to an environmental signal, hypoxia, as the sole stimulus. Hypoxia is a condition of low oxygen tension, occurring in several pathological tissues, which acts in synergy with IFN-gamma to induce full Mphi activation. We transfected the ANA-1 murine Mphi cell line with a construct containing the IFN-gamma gene controlled by a synthetic promoter inducible by hypoxia (HRE3x-Tk), and we characterized the cellular and molecular biology of the engineered Mphi under normoxia or hypoxia. Engineered Mphi in normoxia expressed basal levels of IFN-gamma mRNA and protein that were strongly augmented by shifting the cells to hypoxia. Furthermore, they responded to the synthesized IFN-gamma with induction of IFN-responsive factor-1 and 2'-5'-oligoadenylate synthase expression. Under normoxic conditions, the engineered Mphi had a significant constitutive level of Ia Ags and Fc receptors. Hypoxia induced further augmentation of Ia and Fc expression. Finally, hypoxia induced inducible NO synthase expression, and subsequent reoxygenation led to the production of NO. In conclusion, the engineered Mphi, which produce IFN-gamma in an inducible manner, express new biochemical and functional properties in response to low oxygen environment as the sole stimulus, thereby circumventing the need for costimulation by other immune system-derived signals.


Subject(s)
Cell Culture Techniques/methods , Cell Hypoxia/immunology , Interferon-gamma/biosynthesis , Macrophages/immunology , Macrophages/metabolism , Animals , Cell Hypoxia/genetics , Cell Line , Chemokine CCL4 , Clone Cells , Gene Expression Regulation/immunology , Genetic Vectors/chemical synthesis , Genetic Vectors/immunology , Histocompatibility Antigens Class II/biosynthesis , Histocompatibility Antigens Class II/genetics , Interferon-gamma/genetics , Interferon-gamma/physiology , Macrophage Activation/genetics , Macrophage Inflammatory Proteins/biosynthesis , Macrophage Inflammatory Proteins/genetics , Macrophages/enzymology , Macrophages/physiology , Mice , Mice, Inbred C57BL , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , RNA, Messenger/biosynthesis , Receptors, IgG/biosynthesis , Receptors, IgG/genetics , Response Elements/immunology , Transfection
2.
Gene Ther ; 8(6): 431-41, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11313821

ABSTRACT

The goal of this project was to develop a novel gene transfer system based on macrophages (Mphi) as shuttles of recombinant retroviral vectors carrying therapeutic or marker genes. The murine Mphi cell line WGL5 was used as a source of Mphi for this study. We generated retrovirus-producing Mphi by transducing the WGL5 cells with a replication-defective retroviral vector carrying the enhanced green fluorescent protein (EGFP) reporter gene and the Moloney murine leukemia virus (MoMLV) as helper virus. We demonstrated stable integration of the recombinant retrovirus in the Mphi genome, efficient recombinant retrovirus production, and EGFP gene delivery to different cell lines in vitro. To evaluate Mphi-mediated EGFP gene transfer in vivo, allogeneic mice were injected s.c. with the retrovirus-producing WGL5 Mphi, that gave rise to solid tumor masses at the injection site, highly infiltrated with host leukocytes. We observed EGFP fluorescence in tumor-infiltrating CD4(+) and CD8(+) host T lymphocytes, providing direct evidence of the ability of engineered Mphi to mediate EGFP gene delivery to host cells in vivo. Moreover, we showed that retrovirus-producing Mphi could home to different organs in vivo following i.v. injection into mice. These data demonstrate that Mphi can be engineered as cellular vehicles for recombinant retroviruses carrying heterologous genes and suggest potential applications of this novel vector system for gene therapy.


Subject(s)
Genetic Therapy/methods , Genetic Vectors/administration & dosage , Macrophages/virology , Retroviridae/genetics , T-Lymphocytes/virology , Transduction, Genetic/methods , Animals , CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/virology , Cell Line , Green Fluorescent Proteins , Injections, Intravenous , Injections, Subcutaneous , Luminescent Proteins/genetics , Macrophages/transplantation , Mice , Microscopy, Fluorescence
3.
J Chromatogr B Biomed Sci Appl ; 751(1): 61-8, 2001 Feb 10.
Article in English | MEDLINE | ID: mdl-11232856

ABSTRACT

A HPLC method is described to quantify picolinic acid in milk, blood serum and tissue culture supernatant. The method requires very little sample preparation because acid precipitation allows total recovery of picolinic acid. High specificity and sensitivity were obtained using ion-pair chromatography on a C18 reversed-phase column with tetrabutylammonium hydrogen sulfate as ion pairing reagent. We describe the conditions for the automated testing of multiple samples and for the detection of L-tryptophan and L-kynurenine together with picolinic acid. This system will be utilized to elucidate the relationship between picolinic acid production and human disease. Furthermore, we provide the first evidence of picolinic acid in human blood serum.


Subject(s)
Chromatography, High Pressure Liquid/methods , Picolinic Acids/analysis , Animals , Humans , Milk, Human/chemistry , Picolinic Acids/blood , Rats , Rats, Wistar , Reproducibility of Results , Tumor Cells, Cultured
4.
Transfus Apher Sci ; 24(3): 293-6, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11791706

ABSTRACT

Autologous PBSC transplantation is an integral component of the management of hemato-oncology patients. In order to reduce the number of sessions needed to collect the desired number of repopulating cells there has been significant research activity in developing progressively more and more effective technologies and techniques. Recently our group has been involved in the rejuvenation of the MCS + apparatus for both platelet and PBSC collection. The so called "version A2 protocol" is aimed at collecting PBSC in a very efficient way. This protocol is characterized by high blood flow rates both in the collection and reinfusion (80 ml/min) recirculation (56 ml/min) and collection phases (30 ml/min). Only one recirculation is carried out every 5 cycles and only from 5 to 7 are carried out for a single procedure. Twenty-seven collections were carried out of which 25 were evaluable in terms of PBSC efficiency. These averaged 68.8% in an average procedure time of 3.5-5 h for processing an average of 7,052 ml of blood. The RBC contamination was reduced to approximately 5.02 g of hemoglobin and the average volume of the product to 177 ml. If these results are confirmed, the gap between CFC and DFC PBSC is progressively closing.


Subject(s)
Hematopoietic Stem Cells , Leukapheresis/methods , Adult , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/blood , Breast Neoplasms/drug therapy , Breast Neoplasms/therapy , Caspase 14 , Caspases/administration & dosage , Caspases/pharmacology , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Cyclophosphamide/pharmacology , Female , Granulocyte Colony-Stimulating Factor/pharmacology , Hematologic Neoplasms/blood , Hematologic Neoplasms/drug therapy , Hematologic Neoplasms/therapy , Hematopoietic Stem Cell Mobilization , Hematopoietic Stem Cell Transplantation , Humans , Leukapheresis/instrumentation , Male , Platelet Count , Safety
5.
J Immunol ; 164(6): 3283-91, 2000 Mar 15.
Article in English | MEDLINE | ID: mdl-10706721

ABSTRACT

We previously found that the tryptophan catabolite picolinic acid (PA) is a costimulus for the activation of macrophage effector functions. In this study, we have investigated the ability of PA to modulate the expression of chemokines in macrophages. We demonstrate that PA is a potent activator of the inflammatory chemokines MIP (macrophage inflammatory protein)-1 alpha and MIP-1 beta (MIPs) mRNA expression in mouse macrophages in a dose- and time-dependent fashion and through a de novo protein synthesis-dependent process. The induction by PA occurred within 3 h of treatment and reached a peak in 12 h. The stimulatory effects of PA were selective for MIPs because other chemokines, including monocyte chemoattractant protein-1, RANTES, IFN-gamma-inducible protein-10, MIP-2, and macrophage-derived chemokine, were not induced under the same experimental conditions and were not an epiphenomenon of macrophage activation because IFN-gamma did not affect MIPs expression. Induction of both MIP-1 alpha and MIP-1 beta by PA was associated with transcriptional activation and mRNA stabilization, suggesting a dual molecular mechanism of control. Iron chelation could be involved in MIPs induction by PA because iron sulfate inhibited the process and the iron-chelating agent, desferrioxamine, induced MIPs expression. We propose the existence of a new pathway leading to inflammation initiated by tryptophan catabolism that can communicate with the immune system through the production of PA, followed by secretion of chemokines by macrophages. These results establish the importance of PA as an activator of macrophage proinflammatory functions, providing the first evidence that this molecule can be biologically active without the need for a costimulatory agent.


Subject(s)
Macrophage Inflammatory Proteins/biosynthesis , Macrophages/metabolism , Picolinic Acids/immunology , Tryptophan/metabolism , Adjuvants, Immunologic/pharmacology , Animals , Cell Line , Chemokine CCL4 , Gene Expression Regulation/drug effects , Gene Expression Regulation/immunology , Iron Chelating Agents/pharmacology , Macrophage Inflammatory Proteins/genetics , Macrophages/drug effects , Macrophages/immunology , Mice , Mice, Inbred C57BL , Picolinic Acids/metabolism , Picolinic Acids/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/metabolism , Trans-Activators/immunology , Trans-Activators/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...